MedTrace Logo

Treatment for Nicotine Addiction in Women

NCT02448654 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2020-11-24

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to use a medication tolcapone and or placebo to test if the symptoms of nicotine withdrawal lessens , and or changes in smoking urges, and mental reasoning in female smokers over a 72 hour period.

Conditions

  • Nicotine Dependence

Interventions

DRUG

Tolcapone

Tolcapone will be compared to sugar pill

DRUG

Sugar Pill

The sugar pill (placebo) will be compared to tolcapone

Sponsors & Collaborators

Principal Investigators

  • Elise DeVito, Ph.D. · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-23
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02448654 on ClinicalTrials.gov